메뉴 건너뛰기




Volumn 29, Issue 6, 2010, Pages 599-604

Venous thromboembolism in southern Chinese patients with systemic lupus erythematosus

Author keywords

Antiphospholipid; Complication; Incidence; Outcome; Thrombosis

Indexed keywords

PHOSPHOLIPID ANTIBODY; WARFARIN;

EID: 77954425885     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-009-1364-z     Document Type: Article
Times cited : (20)

References (17)
  • 1
    • 77954425634 scopus 로고    scopus 로고
    • Annual incidence and standardized incidence ratio of cerebrovascular accidents in patients with systemic lupus erythematosus
    • [Epub ahead of print]
    • Mok CC, Ho LY, To CH (2009) Annual incidence and standardized incidence ratio of cerebrovascular accidents in patients with systemic lupus erythematosus. Scand J Rheumatol 18:1-7 [Epub ahead of print]
    • (2009) Scand J Rheumatol , vol.18 , pp. 1-7
    • Mok, C.C.1    Ho, L.Y.2    To, C.H.3
  • 2
    • 0031052874 scopus 로고    scopus 로고
    • Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: Comparison with the Framingham Study
    • Manzi S, Meilahn EN, Rairie JE et al (1997) Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol 145:408-415
    • (1997) Am J Epidemiol , vol.145 , pp. 408-415
    • Manzi, S.1    Meilahn, E.N.2    Rairie, J.E.3
  • 3
    • 3242883121 scopus 로고    scopus 로고
    • Risk of coronary heart disease and stroke in a large British cohort of patients with systemic lupus erythematosus
    • Oxford
    • Bessant R, Hingorani A, Patel L, MacGregor A, Isenberg DA, Rahman A (2004) Risk of coronary heart disease and stroke in a large British cohort of patients with systemic lupus erythematosus. Rheumatology (Oxford) 43:924-929
    • (2004) Rheumatology , vol.43 , pp. 924-929
    • Bessant, R.1    Hingorani, A.2    Patel, L.3    MacGregor, A.4    Isenberg, D.A.5    Rahman, A.6
  • 4
    • 33646467061 scopus 로고    scopus 로고
    • Accelerated atherosclerosis, arterial thromboembolism, and preventive strategies in systemic lupus erythematosus
    • Mok CC (2006) Accelerated atherosclerosis, arterial thromboembolism, and preventive strategies in systemic lupus erythematosus. Scand J Rheumatol 35:85-95
    • (2006) Scand J Rheumatol , vol.35 , pp. 85-95
    • Mok, C.C.1
  • 5
    • 0036896088 scopus 로고    scopus 로고
    • Antiphospholipid antibodies and incidence of venous thrombosis in a cohort of patients with systemic lupus erythematosus
    • Somers E, Magder LS, Petri M (2002) Antiphospholipid antibodies and incidence of venous thrombosis in a cohort of patients with systemic lupus erythematosus. J Rheumatol 29:2531-2536 (Pubitemid 35416957)
    • (2002) Journal of Rheumatology , vol.29 , Issue.12 , pp. 2531-2536
    • Somers, E.1    Magder, L.S.2    Petri, M.3
  • 6
    • 25444489279 scopus 로고    scopus 로고
    • Incidence and risk factors of thromboembolism in systemic lupus erythematosus: A comparison of three ethnic groups
    • Mok CC, Tang SS, To CH, Petri M (2005) Incidence and risk factors of thromboembolism in systemic lupus erythematosus: a comparison of three ethnic groups. Arthritis Rheum 52:2774-2782
    • (2005) Arthritis Rheum , vol.52 , pp. 2774-2782
    • Mok, C.C.1    Tang, S.S.2    To, C.H.3    Petri, M.4
  • 7
    • 22244470734 scopus 로고    scopus 로고
    • LUMINA Study Group
    • Calvo-Alén J, Toloza SM, Fernández M et al (2005) LUMINA Study Group. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXV. Smoking, older age, disease activity, lupus anticoagulant, and glucocorticoid dose as risk factors for the occurrence of venous thrombosis in lupus patients. Arthritis Rheum 52:2060-2068
    • (2005) Arthritis Rheum , vol.52 , pp. 2060-2068
    • Calvo-Alén, J.1    Toloza, S.M.2    Fernández, M.3
  • 8
    • 33748548074 scopus 로고    scopus 로고
    • Risk for incident arterial or venous vascular events varies over the course of systemic lupus erythematosus
    • Chang ER, Pineau CA, Bernatsky S, Neville C, Clarke AE, Fortin PR (2006) Risk for incident arterial or venous vascular events varies over the course of systemic lupus erythematosus. J Rheumatol 33:1780-1784
    • (2006) J Rheumatol , vol.33 , pp. 1780-1784
    • Chang, E.R.1    Pineau, C.A.2    Bernatsky, S.3    Neville, C.4    Clarke, A.E.5    Fortin, P.R.6
  • 10
    • 3042787713 scopus 로고    scopus 로고
    • The contribution of inherited and acquired thrombophilic defects, alone or combined with antiphospholipid antibodies, to venous and arterial thromboembolism in patients with systemic lupus erythematosus
    • Brouwer JL, Bijl M, Veeger NJ, Kluin-Nelemans HC, van der Meer J (2004) The contribution of inherited and acquired thrombophilic defects, alone or combined with antiphospholipid antibodies, to venous and arterial thromboembolism in patients with systemic lupus erythematosus. Blood 104:143-148
    • (2004) Blood , vol.104 , pp. 143-148
    • Brouwer, J.L.1    Bijl, M.2    Veeger, N.J.3    Kluin-Nelemans, H.C.4    Van Der Meer, J.5
  • 11
    • 1642324210 scopus 로고    scopus 로고
    • Pulmonary thromboembolism in Asians/Pacific Islanders in the United States: Analysis of data from the National Hospital Discharge Survey and the United States Bureau of the Census
    • Stein PD, Kayali F, Olson RE, Milford CE (2004) Pulmonary thromboembolism in Asians/Pacific Islanders in the United States: analysis of data from the National Hospital Discharge Survey and the United States Bureau of the Census. Am J Med 116:435-442
    • (2004) Am J Med , vol.116 , pp. 435-442
    • Stein, P.D.1    Kayali, F.2    Olson, R.E.3    Milford, C.E.4
  • 12
    • 0032794523 scopus 로고    scopus 로고
    • Detection of antiannexin IV and V antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus
    • Satoh A, Suzuki K, Takayama E et al (1999) Detection of antiannexin IV and V antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus. J Rheumatol 26:1715-1720
    • (1999) J Rheumatol , vol.26 , pp. 1715-1720
    • Satoh, A.1    Suzuki, K.2    Takayama, E.3
  • 13
    • 34147213486 scopus 로고    scopus 로고
    • Factor XII autoantibodies as a novel marker for thrombosis and adverse obstetric history in patients with systemic lupus erythematosus
    • Bertolaccini ML, Mepani K, Sanna G, Hughes GR, Khamashta MA (2007) Factor XII autoantibodies as a novel marker for thrombosis and adverse obstetric history in patients with systemic lupus erythematosus. Ann Rheum Dis 66:533-536
    • (2007) Ann Rheum Dis , vol.66 , pp. 533-536
    • Bertolaccini, M.L.1    Mepani, K.2    Sanna, G.3    Hughes, G.R.4    Khamashta, M.A.5
  • 14
    • 0142124287 scopus 로고    scopus 로고
    • Antibodies directed to protein S in patients with systemic lupus erythematosus: Prevalence and clinical significance
    • Bertolaccini ML, Sanna G, Ralhan S et al (2003) Antibodies directed to protein S in patients with systemic lupus erythematosus: prevalence and clinical significance. Thromb Haemost 90:636-641
    • (2003) Thromb Haemost , vol.90 , pp. 636-641
    • Bertolaccini, M.L.1    Sanna, G.2    Ralhan, S.3
  • 15
    • 0036036951 scopus 로고    scopus 로고
    • Acquired activated protein C resistance is associated with the co-existence of antiprothrombin antibodies and lupus anticoagulant activity in patients with systemic lupus erythematosus
    • Nojima J, Kuratsune H, Suehisa E et al (2002) Acquired activated protein C resistance is associated with the co-existence of antiprothrombin antibodies and lupus anticoagulant activity in patients with systemic lupus erythematosus. Br J Haematol 118:577-583
    • (2002) Br J Haematol , vol.118 , pp. 577-583
    • Nojima, J.1    Kuratsune, H.2    Suehisa, E.3
  • 16
    • 0034791684 scopus 로고    scopus 로고
    • Anti-prothrombin antibodies combined with lupus anti-coagulant activity is an essential risk factor for venous thromboembolism in patients with systemic lupus erythematosus
    • Nojima J, Kuratsune H, Suehisa E et al (2001) Anti-prothrombin antibodies combined with lupus anti-coagulant activity is an essential risk factor for venous thromboembolism in patients with systemic lupus erythematosus. Br J Haematol 114:647-654
    • (2001) Br J Haematol , vol.114 , pp. 647-654
    • Nojima, J.1    Kuratsune, H.2    Suehisa, E.3
  • 17
    • 0020436689 scopus 로고
    • The 1982 revised criteria for the classification of systemic lupus erythematosus
    • Tan EM, Cohen AS, Fries JF et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271-1277
    • (1982) Arthritis Rheum , vol.25 , pp. 1271-1277
    • Tan, E.M.1    Cohen, A.S.2    Fries, J.F.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.